Last reviewed · How we verify

NCT04066218

Sexual Function Screening in Childhood Cancer Survivors

Completed Last updated 30 June 2022
What this trial tests

trial testing Interviews in Childhood Cancer in 24 participants. Completed in 1 June 2022.

Timeline
16 September 2019
Primary endpoint
7 April 2020
1 June 2022

Quick facts

Lead sponsorUniversity of Colorado, Denver
StatusCompleted
Study typeOBSERVATIONAL
Enrollment24
Start date16 September 2019
Primary completion7 April 2020
Estimated completion1 June 2022
Sites2 locations across United States

Drugs / interventions tested

Conditions studied

Sponsor

University of Colorado, Denver

Who can join

Adults 15 to 24, any sex, with Childhood Cancer or Survivorship. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is a qualitative research study involving semistructured interviews and Think-Aloud methodology during completion of a clinical screening tool. All participants will undergo the same semistructured interviews.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Interviews

Trials testing the same drug.

Other recruiting trials for Childhood Cancer

Currently open trials in the same condition.

Other University of Colorado, Denver trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04066218.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing